Leica Biosystems is a global leader in cancer diagnostics with over 150 years of innovation history. As part of the Danaher Corporation, Leica Biosystems develops and markets comprehensive workflow solutions for anatomical pathology. The company offers a unique portfolio that covers the entire diagnostic process from biopsy to sample preparation and staining to imaging and reporting. This enables physicians to make faster and more accurate cancer diagnoses, thereby significantly improving patient care[2][3][7].

The mission of Leica Biosystems is "Advancing Cancer Diagnostics, Improving Lives" - that is, the continuous improvement of cancer diagnostics to positively change the lives of patients worldwide. With more than 1.6 million diagnoses per week, the company contributes globally to transforming fears into secure diagnoses and treatment options. Innovation and technological leadership shape the corporate philosophy; Leica Biosystems continuously invests in research and development to advance digital pathology and AI-supported image analysis[2][5][8].

Sustainability also plays an important role at Leica Biosystems. The company integrates sustainable practices throughout its value chain and promotes responsible action in healthcare. The focus is on long-term resource efficiency and minimizing environmental impact, also within the framework of global standards and certifications[9].

Leica Biosystems has an international presence with locations in Germany, the USA, Great Britain and other countries. It regularly collaborates with leading medical research institutions to develop innovative diagnostic solutions - including with partners such as the Mayo Clinic and Galena Biopharma[1].

Core products and services:

Complete solutions for the pathology workflow: biopsy preparation, sample transformation, staining technologies, automated tissue analysis
Digital pathology tools including imaging and AI-based diagnostic support
Research solutions and companion diagnostics for personalized cancer treatments
Services related to tissue staining, multiparametric analysis and image evaluation[1][2][4][8]

With over a century and a half of experience, Leica Biosystems combines technical precision with a strong commitment to improving clinical outcomes and patient well-being. By integrating all process steps in one hand, the company sets standards in cancer diagnostics and makes a significant contribution to accelerating life-changing therapies.

This description concisely summarizes the most important aspects of Leica Biosystems and underlines the global importance as well as the vision of the company in the field of cancer diagnostics and pathology solutions.

Quellen:

1 - https://en.wikipedia.org/wiki/Leica_Biosystems
2 - https://www.danaher.com/our-businesses/diagnostics/leica-biosystems
3 - https://www.leicabiosystems.com/us/about/
4 - https://www.leicabiosystems.com/about/?page=1
5 - https://www.leicabiosystems.com/us/150-years/
6 - https://jobs.danaher.com/global/en/leica-biosystems
7 - https://www.leicabiosystems.com/us/
8 - https://www.leicabiosystems.com/us/about/innovations/
9 - https://www.leicabiosystems.com/us/about/worldwide-operations/

Don't miss your dream job!

Digital Pathology Program Manager (f/m/d)

Digital Pathology Program Manager (f/m/d)

Don't miss your dream job!

Digital Pathology Program Manager (f/m/d)

Digital Pathology Program Manager (f/m/d)